[Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
Fournier
A
A
Aparicio
M
M
D000328:Adult; D000535:Aluminum / Q000009:adverse effects; D000596:Amino Acids / Q000627:therapeutic use; D002112:Calcifediol / Q000008:administration & dosage / Q000627:therapeutic use; D002117:Calcitriol / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology / Q000517:prevention & control*; D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000150:complications / Q000517:prevention & control; D006996:Hypocalcemia / Q000209:etiology / Q000628:therapy; D007223:Infant; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D009748:Nutrition Disorders / Q000150:complications / Q000628:therapy; D010018:Osteomalacia / Q000209:etiology; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010758:Phosphorus / Q000097:blood; D017410:Practice Guidelines as Topic; D017582:Renal Replacement Therapy; D014808:Vitamin D Deficiency / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control
D000596:Amino Acids; D004044:Dietary Proteins; D010758:Phosphorus; D000535:Aluminum; D002117:Calcitriol; D002112:Calcifediol
Lettre aux auteurs des recommandations pour la pratique clinique concernant la prévention de l'ostéodystrophie rénale avant le stade de l'épuration extra-rénale.